E-Learning

US stock futures rose as investors digested reassuring signals from Federal Reserve Chair Jerome Powell after the central bank held interest rates steady on Wednesday.

Jabil shares surged Thursday after the circuit board maker reported better-than-expected fiscal second-quarter results and issued an upbeat outlook.

(Bloomberg) -- Wall Street brokers have started selling insurers’ claims tied to Los Angeles’ deadly wildfires, which may trigger a payout from the utilities blamed for the destruction, according to people familiar with the matter. Most Read from BloombergNew York Subway Ditches MetroCard After 32 Years for Tap-And-GoAmtrak CEO Departs Amid Threats of a Transit Funding PullbackDespite Cost-Cutting Moves, Trump Plans to Remake DC in His StyleLA Faces $1 Billion Budget Hole, Warns of Thousands of

Shares of footwear and accessories discount retailer Designer Brands (NYSE:DBI) jumped 13.8% in the morning session after the company reported improved fourth-quarter 2024 results: Same-Store Sales grew modestly (vs -7.3% in the same quarter last year), and gross margin blew past expectations. This marked the first positive growth in nine quarters, signaling early traction in the company's turnaround efforts.

Shares of discount retailer Five Below (NASDAQ:FIVE) jumped 12.7% in the pre-market session after the company reported impressive fourth-quarter (Q1 2025) results: Revenue, EPS, and EBITDA all exceeded Wall Street's estimates. Sales growth was primarily driven by store expansion, with a 14.7% increase in locations compared to the previous year.

Shares of online used car dealer Carvana (NYSE: CVNA) jumped 9.6% in the morning session after Piper Sandler analysts upgraded the stock from Neutral to Buy, suggesting that the company's reduced valuation presented a buying opportunity. The analysts added "We would use the recent sell-off to accumulate CVNA shares."

Shares of heavy equipment distributor Titan Machinery (NASDAQ:TITN) jumped 17% in the afternoon session after the company reported decent fourth-quarter results which blew past analysts' revenue expectations. Adding to the positive, free cash flow improved significantly.

Mounting economic concerns have threatened to derail the AI trade, putting Nvidia stock on track to have its worst quarter since 2022.

US President Donald Trump's trade war is already causing market jitters, particularly in export-focused Asia.

Here are the local and international drugmakers also eyeing the Indian market and looking to introduce rivals to Lilly's drug: NOVO NORDISK The Danish drugmaker had said it aims to launch its blockbuster weight-loss drug, Wegovy, in India by 2026. The active ingredient in Wegovy is semaglutide, which is likely to go off-patent in 2026 in India. Wegovy and Lilly's Mounjaro belong to the same class of treatments called GLP-1 agonists, which soared into popularity globally triggering a shortage of supply.